Abstract
Abstract1. In vivo metabolism studies have shown N-cyclopropyl-2-chlorophenoxy-ethylamine (Lilly 51641) to be extensively metabolized in the rat. Those metabolites identified include 2-chlorophenoxyacetic acid, N-cyclopropyl-4-hydroxy-2-chlorophenoxyethylamine and 4-hydroxy-2-chlorophenoxyethanol, together with a number of minor products. The major route of elimination of these metabolites is through the kidney.2. The major in vitro metabolites of Lilly 51641 have been identified as 2-chlorophenoxyethylamine, 2-chlorophenoxyacetaldehyde, 2-chlorophenoxyacetic acid and 2-chlorophenoxyethanol. It thus appears that this drug is metabolized by the following sequence: N-dealkylation, deamination and aldehyde oxidation or reduction.3. Aromatic hydroxylation was found to be an independent but important mechanism involved in the metabolism of Lilly 51641.4. Human urinary metabolites of Lilly 51641 were separated and identified. The nature of these metabolites indicated that the same mechanisms of detoxication wer...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Xenobiotica; the fate of foreign compounds in biological systems
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
